Bir Shyamal C, Patra Devi Prasad, Maiti Tanmoy Kumar, Bollam Papireddy, Minagar Alireza, Nanda Anil
Department of Neurosurgery, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Department of Neurology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
World Neurosurg. 2017 May;101:170-179. doi: 10.1016/j.wneu.2017.01.105. Epub 2017 Feb 6.
Patients with small (<3 cm) intracranial meningiomas can be either observed or treated. Treatment can be either radiosurgery or microsurgery if and when tumor progression occurs. We compared local tumor growth control and recurrence-free survival (RFS) of microsurgical resection and radiosurgery in small intracranial meningiomas and identified predictors of unfavorable outcome.
A retrospective review (2005-2016) was performed of 90 consecutive patients with intracranial meningiomas who underwent either microsurgery (n = 31) or Gamma Knife radiosurgery (GKRS) (n = 59). The study population was evaluated clinically and radiographically after treatment.
GKRS in meningiomas showed a significantly higher percentage of local control of tumor growth compared with microsurgery (P = 0.02) 5 and 10 years (P = 0.003) after treatment. The median RFS was also significantly higher in the GKRS group compared with the microsurgery group (P = 0.04). There was no difference in RFS between Simpson grade I resection and GKRS (P = 0.69). In univariate analysis, RFS after procedures was significantly affected by tumor involvement of cranial nerves, presence of comorbidities, and preoperative Karnofsky performance scale score ≤70. In multivariate analysis, only preoperative Karnofsky performance scale score ≤70 was a predictor of unfavorable outcome.
GKRS offers a high rate of tumor control and longer RFS that is comparable to Simpson grade I resection. Subtotal resection is not a good choice for small meningiomas. The treatment procedure should be tailored according to the presence of comorbidities and the maximum benefit for the patient.
小型(<3 cm)颅内脑膜瘤患者可选择观察或治疗。若肿瘤进展,治疗方式可以是放射外科手术或显微外科手术。我们比较了小型颅内脑膜瘤显微手术切除和放射外科手术的局部肿瘤生长控制情况及无复发生存率(RFS),并确定了不良预后的预测因素。
对2005年至2016年连续90例行显微手术(n = 31)或伽玛刀放射外科手术(GKRS)(n = 59)的颅内脑膜瘤患者进行回顾性研究。治疗后对研究人群进行临床和影像学评估。
与显微手术相比,脑膜瘤GKRS在治疗后5年(P = 0.02)和10年(P = 0.003)时显示出显著更高的肿瘤生长局部控制率。GKRS组的中位RFS也显著高于显微手术组(P = 0.04)。辛普森I级切除与GKRS之间的RFS无差异(P = 0.69)。在单因素分析中,手术后的RFS受脑神经受累、合并症的存在以及术前卡诺夫斯基表现量表评分≤70的显著影响。在多因素分析中,只有术前卡诺夫斯基表现量表评分≤70是不良预后的预测因素。
GKRS提供了较高的肿瘤控制率和较长的RFS,与辛普森I级切除相当。次全切除对于小型脑膜瘤不是一个好的选择。治疗方案应根据合并症的存在情况和对患者的最大益处进行调整。